digital diabetes management
Western Sydney Diabetes adopts the mobile solution to automate patient engagement.
i-SENS is also seeking CE certification for its CGM product in Europe.
The CGM-based service will begin in Q4.
It is part of an artificial pancreas system that mimics the human body's closed-loop system for insulin production.
The market comprised $98 million in revenue during 2017, and is beginning to move away from stand-alone devices or apps.